{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Anaheim",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82335",
      "recalling_firm": "Preferred Pharmaceuticals, Inc",
      "address_1": "1250 N Lakeview Ave Ste O",
      "address_2": "N/A",
      "postal_code": "92807-1801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "California, Georgia, Indiana",
      "recall_number": "D-1051-2019",
      "product_description": "Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc. 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807.",
      "product_quantity": "530",
      "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.",
      "recall_initiation_date": "20190306",
      "center_classification_date": "20190321",
      "termination_date": "20230330",
      "report_date": "20190327",
      "code_info": "Count, lots, expiry: a) 30-count bottle C2218C, exp 9/2020, D1318E, exp 10/2020; b) 90-count bottle C2719J, exp 9/2020, E1818B, exp 10/2020."
    }
  ]
}